Skip to main content
. 2022 Mar 30;14(4):743. doi: 10.3390/pharmaceutics14040743

Figure 8.

Figure 8

Schematic illustration for the preparation of RGD-LP-CHMSN-ATO for hepatic carcinoma therapy. Reproduced with permission from ref. [56], Elsevier, 2017.